Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Victoria C. Hodgkinson"'
Autor:
Penelope McManus, Tapan Mahapatra, Dalia ELFadl, Philip J. Drew, Vijay Agarwal, P.J. Kneeshaw, Victoria C. Hodgkinson, John N. Fox, Michael J. Lind, Lynn Cawkwell
Publikováno v:
Journal of Proteomics. 75:2745-2752
Neoadjuvant chemotherapy is used to treat oestrogen receptor-positive breast cancer however chemo-resistance is a major obstacle in this molecular subtype. The ability to predict tumour response would allow chemotherapy administration to be directed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7da89b15cc632c870d6e4edfaf4ce4df
https://doi.org/10.1016/j.jprot.2012.03.049
https://doi.org/10.1016/j.jprot.2012.03.049
Autor:
P.J. Kneeshaw, Tapan Mahapatra, Dalia ELFadl, Ervine D. Long, Penelope McManus, Michael J. Lind, John N. Fox, V. Garimella, Philip J. Drew, Vijay Agarwal, Charlotte Russell, Lynn Cawkwell, Victoria C. Hodgkinson
Publikováno v:
Journal of Proteomics. 75:1276-1283
Introduction Chemotherapy resistance is a major obstacle in effective neoadjuvant treatment for estrogen receptor-positive breast cancer. The ability to predict tumour response would allow chemotherapy administration to be directed towards only those
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d3b0c009215880154ec7c6e03b6b76
https://doi.org/10.1016/j.jprot.2011.11.005
https://doi.org/10.1016/j.jprot.2011.11.005
Publikováno v:
Expert Review of Proteomics. 8:535-552
The individualization of radiotherapy treatment would be beneficial for cancer patients; however, there are no predictive biomarkers of radiotherapy resistance in routine clinical use. This article describes the body of work in this field where compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8159dfd4dcc1417aa950050c28f3f919
https://doi.org/10.1586/epr.11.32
https://doi.org/10.1586/epr.11.32
Autor:
Victoria C. Hodgkinson, Ervine D. Long, Lynn Cawkwell, Lucy Scaife, Michael J. Lind, Dalia ELFadl, Philip J. Drew
Publikováno v:
The Breast. 20:334-337
Breast conserving therapy is a currently accepted method for managing patients with early stage breast cancer. However, approximately 7% of patients may develop loco-regional tumour recurrence within 5 years. We previously reported that expression of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f8f8f6befafc9984962971c44815ec7
https://doi.org/10.1016/j.breast.2011.02.017
https://doi.org/10.1016/j.breast.2011.02.017
Autor:
Michael J. Lind, Victoria C. Hodgkinson, Vijay Agarwal, Lynn Cawkwell, Gina L. Eagle, Lucy Scaife
Publikováno v:
International journal of oncology. 42(3)
We have previously shown that specific COX-2 inhibitors, including DuP 697, have anti-proliferative effects on mesothelioma cells and potentiate the cytotoxicity of pemetrexed. Here, we used a novel proteomic approach to explore the mechanism of acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ec416dac81abdf754b2107d942dcb61
https://pubmed.ncbi.nlm.nih.gov/23338544
https://pubmed.ncbi.nlm.nih.gov/23338544
Publikováno v:
Journal of proteomics. 74(5)
Antibody microarrays are powerful new tools in the field of comparative proteomics. The success of the biomarker discovery pipeline relies on the quality of data generated in the discovery phase and careful selection of proteins for the verification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb9d37bd643ceb76ef81dc4892bbfbd
https://pubmed.ncbi.nlm.nih.gov/21338725
https://pubmed.ncbi.nlm.nih.gov/21338725
Publikováno v:
Cancer letters. 294(1)
This review describes and discusses the advantages and limitations of proteomic approaches in the identification of biomarkers associated with chemotherapy resistance. Both gel-based (two-dimensional polyacrylamide gel electrophoresis) and gel-free (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a10cac49d02a5fe55cb298098ff860e4
https://pubmed.ncbi.nlm.nih.gov/20176436
https://pubmed.ncbi.nlm.nih.gov/20176436
Autor:
Victoria C. Hodgkinson, Penelope McManus, Tapan Mahapatra, Phil Drew, Michael J. Lind, Lucy Scaife, Tasadooq Hussain, Vijay Agarwal, Lynn Cawkwell, P.J. Kneeshaw
Publikováno v:
European Journal of Surgical Oncology (EJSO). 39:480-481
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a226838ec9602bed01112efcc9039fb1
https://doi.org/10.1016/j.ejso.2013.01.105
https://doi.org/10.1016/j.ejso.2013.01.105
Autor:
Tapan Mahapatra, Penelope McManus, Vijay Agarwal, Lucy Scaife, Lynn Cawkwell, Victoria C. Hodgkinson, Michael J. Lind, Phil Drew, P.J. Kneeshaw, Tasadooq Hussain
Publikováno v:
European Journal of Surgical Oncology (EJSO). 39:S78
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c209fb631db1944ef5cbf93d3c5aeb12
https://doi.org/10.1016/j.ejso.2013.07.100
https://doi.org/10.1016/j.ejso.2013.07.100
Autor:
Victoria C. Hodgkinson, Tasadooq Hussain, Tapan Mahapatra, Lynn Cawkwell, Lucy Scaife, P.J. Kneeshaw, Michael J. Lind, Penelope McManus, Vijay Agarwal
Publikováno v:
International Journal of Surgery. (8):604
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::031861f90b20cbafd4cfc9c0ee138300